 | • レポートコード：QYR9N7612 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、骨髄増殖性疾患の薬のグローバル市場について調査・分析したレポートで、種類別（Ph+ CML 、Ph- MPN ）、用途別（病院、薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・骨髄増殖性疾患の薬の世界市場規模 ・主要企業別市場シェア ・骨髄増殖性疾患の薬の世界市場規模：種類別（Ph+ CML 、Ph- MPN ） ・骨髄増殖性疾患の薬の世界市場規模：用途別（病院、薬局） ・骨髄増殖性疾患の薬のアメリカ市場規模（種類別、用途別） ・骨髄増殖性疾患の薬のヨーロッパ市場規模（種類別、用途別） ・骨髄増殖性疾患の薬の中国市場規模（種類別、用途別） ・骨髄増殖性疾患の薬の日本市場規模（種類別、用途別） ・骨髄増殖性疾患の薬の東南アジア市場規模（種類別、用途別） ・骨髄増殖性疾患の薬のインド市場規模（種類別、用途別） ・骨髄増殖性疾患の薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・骨髄増殖性疾患の薬の世界市場予測（2019年-2025年） ・骨髄増殖性疾患の薬の地域別市場予測（2019年-2025年） ... |
hronic myeloproliferative disorders are rare hematological malignances that involve abnormal accumulation of mature myeloid cells (red blood cells, granulocytes, and platelets) and their precursors (myelocytes, metamyelocytes, nucleated red blood cells, and megakaryocytes) in the peripheral blood and bone marrow.The available drugs have not shown disease-modifying activity and are still largely inadequate for managing major unmet needs, which include prevention of hematological progression, normalization of life span, reduction of cardiovascular complications, and improved quality of life. Strong unmet needs within the market present a key opportunity to develop breakthrough first-in-class therapies.
In 2018, the global Myeloproliferative Disorders Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Myeloproliferative Disorders Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myeloproliferative Disorders Drugs development in United States, Europe and China.
The key players covered in this study
Celgene
Bristol-Myers Squibb
Gamida Cell
Incyte
Geron
Promedior
Johnson & Johnson
…
Market segment by Type, the product can be split into
Ph+ CML
Ph- MPN
Market segment by Application, split into
Hospitals
Pharmacy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Myeloproliferative Disorders Drugs status, future forecast, growth opportunity, key market and key players.
To present the Myeloproliferative Disorders Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Myeloproliferative Disorders Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myeloproliferative Disorders Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Ph+ CML
1.4.3 Ph- MPN
1.5 Market by Application
1.5.1 Global Myeloproliferative Disorders Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Myeloproliferative Disorders Drugs Market Size
2.2 Myeloproliferative Disorders Drugs Growth Trends by Regions
2.2.1 Myeloproliferative Disorders Drugs Market Size by Regions (2014-2025)
2.2.2 Myeloproliferative Disorders Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Myeloproliferative Disorders Drugs Market Size by Manufacturers
3.1.1 Global Myeloproliferative Disorders Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Myeloproliferative Disorders Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myeloproliferative Disorders Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Myeloproliferative Disorders Drugs Key Players Head office and Area Served
3.3 Key Players Myeloproliferative Disorders Drugs Product/Solution/Service
3.4 Date of Enter into Myeloproliferative Disorders Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Myeloproliferative Disorders Drugs Market Size by Type (2014-2019)
4.2 Global Myeloproliferative Disorders Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Myeloproliferative Disorders Drugs Market Size (2014-2019)
5.2 Myeloproliferative Disorders Drugs Key Players in United States
5.3 United States Myeloproliferative Disorders Drugs Market Size by Type
5.4 United States Myeloproliferative Disorders Drugs Market Size by Application
6 Europe
6.1 Europe Myeloproliferative Disorders Drugs Market Size (2014-2019)
6.2 Myeloproliferative Disorders Drugs Key Players in Europe
6.3 Europe Myeloproliferative Disorders Drugs Market Size by Type
6.4 Europe Myeloproliferative Disorders Drugs Market Size by Application
7 China
7.1 China Myeloproliferative Disorders Drugs Market Size (2014-2019)
7.2 Myeloproliferative Disorders Drugs Key Players in China
7.3 China Myeloproliferative Disorders Drugs Market Size by Type
7.4 China Myeloproliferative Disorders Drugs Market Size by Application
8 Japan
8.1 Japan Myeloproliferative Disorders Drugs Market Size (2014-2019)
8.2 Myeloproliferative Disorders Drugs Key Players in Japan
8.3 Japan Myeloproliferative Disorders Drugs Market Size by Type
8.4 Japan Myeloproliferative Disorders Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Myeloproliferative Disorders Drugs Market Size (2014-2019)
9.2 Myeloproliferative Disorders Drugs Key Players in Southeast Asia
9.3 Southeast Asia Myeloproliferative Disorders Drugs Market Size by Type
9.4 Southeast Asia Myeloproliferative Disorders Drugs Market Size by Application
10 India
10.1 India Myeloproliferative Disorders Drugs Market Size (2014-2019)
10.2 Myeloproliferative Disorders Drugs Key Players in India
10.3 India Myeloproliferative Disorders Drugs Market Size by Type
10.4 India Myeloproliferative Disorders Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Myeloproliferative Disorders Drugs Market Size (2014-2019)
11.2 Myeloproliferative Disorders Drugs Key Players in Central & South America
11.3 Central & South America Myeloproliferative Disorders Drugs Market Size by Type
11.4 Central & South America Myeloproliferative Disorders Drugs Market Size by Application
12 International Players Profiles
12.1 Celgene
12.1.1 Celgene Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myeloproliferative Disorders Drugs Introduction
12.1.4 Celgene Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.1.5 Celgene Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myeloproliferative Disorders Drugs Introduction
12.2.4 Bristol-Myers Squibb Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Gamida Cell
12.3.1 Gamida Cell Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myeloproliferative Disorders Drugs Introduction
12.3.4 Gamida Cell Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.3.5 Gamida Cell Recent Development
12.4 Incyte
12.4.1 Incyte Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myeloproliferative Disorders Drugs Introduction
12.4.4 Incyte Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.4.5 Incyte Recent Development
12.5 Geron
12.5.1 Geron Company Details
12.5.2 Company Description and Business Overview
12.5.3 Myeloproliferative Disorders Drugs Introduction
12.5.4 Geron Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.5.5 Geron Recent Development
12.6 Promedior
12.6.1 Promedior Company Details
12.6.2 Company Description and Business Overview
12.6.3 Myeloproliferative Disorders Drugs Introduction
12.6.4 Promedior Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.6.5 Promedior Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Myeloproliferative Disorders Drugs Introduction
12.7.4 Johnson & Johnson Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Myeloproliferative Disorders Drugs Key Market Segments
Table Key Players Myeloproliferative Disorders Drugs Covered
Table Global Myeloproliferative Disorders Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Myeloproliferative Disorders Drugs Market Size Market Share by Type 2014-2025
Figure Ph+ CML Figures
Table Key Players of Ph+ CML
Figure Ph- MPN Figures
Table Key Players of Ph- MPN
Table Global Myeloproliferative Disorders Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacy Case Studies
Figure Myeloproliferative Disorders Drugs Report Years Considered
Table Global Myeloproliferative Disorders Drugs Market Size 2014-2025 (Million US$)
Figure Global Myeloproliferative Disorders Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Share by Regions 2014-2019
Figure Global Myeloproliferative Disorders Drugs Market Share by Regions 2014-2019
Figure Global Myeloproliferative Disorders Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Myeloproliferative Disorders Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Share by Manufacturers (2014-2019)
Figure Global Myeloproliferative Disorders Drugs Market Share by Manufacturers in 2018
Table Global Myeloproliferative Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Myeloproliferative Disorders Drugs Product/Solution/Service
Table Date of Enter into Myeloproliferative Disorders Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Size Share by Type (2014-2019)
Figure Global Myeloproliferative Disorders Drugs Market Size Market Share by Type (2014-2019)
Table Global Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Myeloproliferative Disorders Drugs Market Size Share by Application (2014-2019)
Figure Global Myeloproliferative Disorders Drugs Market Size Market Share by Application (2014-2019)
Figure Global Myeloproliferative Disorders Drugs Revenue Market Share by Application in 2018
Figure United States Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table United States Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table United States Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure Europe Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table Europe Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table Europe Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure China Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table China Myeloproliferative Disorders Drugs Market Size by Type (2014-20189) (Million US$)
Table China Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table China Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table China Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure Japan Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table Japan Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table Japan Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table Southeast Asia Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table Southeast Asia Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure India Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table India Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table India Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table India Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table India Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Figure Central & South America Myeloproliferative Disorders Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Myeloproliferative Disorders Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Myeloproliferative Disorders Drugs Market Share (2018-2019)
Table Central & South America Myeloproliferative Disorders Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Myeloproliferative Disorders Drugs Market Share by Type (2014-2019)
Table Central & South America Myeloproliferative Disorders Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Myeloproliferative Disorders Drugs Market Share by Application (2014-2019)
Table Celgene Company Details
Table Celgene Revenue in Myeloproliferative Disorders Drugs Business (2014-2019) (Million US$)
Figure Celgene Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Celgene Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Gamida Cell Company Details
Table Gamida Cell Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Gamida Cell Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Gamida Cell Recent Development
Table Incyte Company Details
Table Incyte Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Incyte Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Incyte Recent Development
Table Geron Company Details
Table Geron Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Geron Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Geron Recent Development
Table Promedior Company Details
Table Promedior Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Promedior Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Promedior Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Myeloproliferative Disorders Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Myeloproliferative Disorders Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Global Myeloproliferative Disorders Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Myeloproliferative Disorders Drugs Market Size Share by Regions (2019-2025)
Figure Global Myeloproliferative Disorders Drugs Market Size Share by Regions in 2025
Figure United States Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Myeloproliferative Disorders Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Myeloproliferative Disorders Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Myeloproliferative Disorders Drugs Market Size by Product (2019-2025)
Figure Global Myeloproliferative Disorders Drugs Market Size by Product in 2025
Table Global Myeloproliferative Disorders Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Myeloproliferative Disorders Drugs Market Size by Application (2019-2025)
Figure Global Myeloproliferative Disorders Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のパニック障害市場：市場規模・現状・予測 Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used incl…- 世界の精神神経疾患および治療市場：市場規模・現状・予測 Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…
- 世界の副甲状腺疾患市場：市場規模・現状・予測 Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hyp…
- 世界の膝・股関節障害市場：市場規模・現状・予測 Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …
- 世界の単遺伝性疾患検査市場：市場規模・現状・予測 According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the co…